Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Intravitreal Injectable Market Definition
1.2 Market Segments
1.2.1 Market by Drug
1.2.2 Market by Disease
1.3 Global Intravitreal Injectable Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Intravitreal Injectable Overall Market Size
2.1 Global Intravitreal Injectable Market Size: 2021 VS 2028
2.2 Global Intravitreal Injectable Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Intravitreal Injectable Sales: 2017-2028
3 Company Landscape
3.1 Top Intravitreal Injectable Players in Global Market
3.2 Top Global Intravitreal Injectable Companies Ranked by Revenue
3.3 Global Intravitreal Injectable Revenue by Companies
3.4 Global Intravitreal Injectable Sales by Companies
3.5 Global Intravitreal Injectable Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Intravitreal Injectable Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Intravitreal Injectable Product Type
3.8 Tier 1, Tier 2 and Tier 3 Intravitreal Injectable Players in Global Market
3.8.1 List of Global Tier 1 Intravitreal Injectable Companies
3.8.2 List of Global Tier 2 and Tier 3 Intravitreal Injectable Companies
4 Sights by Product
4.1 Overview
4.1.1 By Drug - Global Intravitreal Injectable Market Size Markets, 2021 & 2028
4.1.2 Anti-VEGF
4.1.3 Steroids
4.1.4 Others
4.2 By Drug - Global Intravitreal Injectable Revenue & Forecasts
4.2.1 By Drug - Global Intravitreal Injectable Revenue, 2017-2022
4.2.2 By Drug - Global Intravitreal Injectable Revenue, 2023-2028
4.2.3 By Drug - Global Intravitreal Injectable Revenue Market Share, 2017-2028
4.3 By Drug - Global Intravitreal Injectable Sales & Forecasts
4.3.1 By Drug - Global Intravitreal Injectable Sales, 2017-2022
4.3.2 By Drug - Global Intravitreal Injectable Sales, 2023-2028
4.3.3 By Drug - Global Intravitreal Injectable Sales Market Share, 2017-2028
4.4 By Drug - Global Intravitreal Injectable Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Disease
5.1 Overview
5.1.1 By Disease - Global Intravitreal Injectable Market Size, 2021 & 2028
5.1.2 Macular Degeneration
5.1.3 Macular Edema
5.1.4 Uveitis
5.1.5 Retinal Vein Occlusion
5.1.6 Others
5.2 By Disease - Global Intravitreal Injectable Revenue & Forecasts
5.2.1 By Disease - Global Intravitreal Injectable Revenue, 2017-2022
5.2.2 By Disease - Global Intravitreal Injectable Revenue, 2023-2028
5.2.3 By Disease - Global Intravitreal Injectable Revenue Market Share, 2017-2028
5.3 By Disease - Global Intravitreal Injectable Sales & Forecasts
5.3.1 By Disease - Global Intravitreal Injectable Sales, 2017-2022
5.3.2 By Disease - Global Intravitreal Injectable Sales, 2023-2028
5.3.3 By Disease - Global Intravitreal Injectable Sales Market Share, 2017-2028
5.4 By Disease - Global Intravitreal Injectable Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Intravitreal Injectable Market Size, 2021 & 2028
6.2 By Region - Global Intravitreal Injectable Revenue & Forecasts
6.2.1 By Region - Global Intravitreal Injectable Revenue, 2017-2022
6.2.2 By Region - Global Intravitreal Injectable Revenue, 2023-2028
6.2.3 By Region - Global Intravitreal Injectable Revenue Market Share, 2017-2028
6.3 By Region - Global Intravitreal Injectable Sales & Forecasts
6.3.1 By Region - Global Intravitreal Injectable Sales, 2017-2022
6.3.2 By Region - Global Intravitreal Injectable Sales, 2023-2028
6.3.3 By Region - Global Intravitreal Injectable Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Intravitreal Injectable Revenue, 2017-2028
6.4.2 By Country - North America Intravitreal Injectable Sales, 2017-2028
6.4.3 US Intravitreal Injectable Market Size, 2017-2028
6.4.4 Canada Intravitreal Injectable Market Size, 2017-2028
6.4.5 Mexico Intravitreal Injectable Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Intravitreal Injectable Revenue, 2017-2028
6.5.2 By Country - Europe Intravitreal Injectable Sales, 2017-2028
6.5.3 Germany Intravitreal Injectable Market Size, 2017-2028
6.5.4 France Intravitreal Injectable Market Size, 2017-2028
6.5.5 U.K. Intravitreal Injectable Market Size, 2017-2028
6.5.6 Italy Intravitreal Injectable Market Size, 2017-2028
6.5.7 Russia Intravitreal Injectable Market Size, 2017-2028
6.5.8 Nordic Countries Intravitreal Injectable Market Size, 2017-2028
6.5.9 Benelux Intravitreal Injectable Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Intravitreal Injectable Revenue, 2017-2028
6.6.2 By Region - Asia Intravitreal Injectable Sales, 2017-2028
6.6.3 China Intravitreal Injectable Market Size, 2017-2028
6.6.4 Japan Intravitreal Injectable Market Size, 2017-2028
6.6.5 South Korea Intravitreal Injectable Market Size, 2017-2028
6.6.6 Southeast Asia Intravitreal Injectable Market Size, 2017-2028
6.6.7 India Intravitreal Injectable Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Intravitreal Injectable Revenue, 2017-2028
6.7.2 By Country - South America Intravitreal Injectable Sales, 2017-2028
6.7.3 Brazil Intravitreal Injectable Market Size, 2017-2028
6.7.4 Argentina Intravitreal Injectable Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Intravitreal Injectable Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Intravitreal Injectable Sales, 2017-2028
6.8.3 Turkey Intravitreal Injectable Market Size, 2017-2028
6.8.4 Israel Intravitreal Injectable Market Size, 2017-2028
6.8.5 Saudi Arabia Intravitreal Injectable Market Size, 2017-2028
6.8.6 UAE Intravitreal Injectable Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Regeneron Pharmaceuticals (Eylea)
7.1.1 Regeneron Pharmaceuticals (Eylea) Corporate Summary
7.1.2 Regeneron Pharmaceuticals (Eylea) Business Overview
7.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Major Product Offerings
7.1.4 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales and Revenue in Global (2017-2022)
7.1.5 Regeneron Pharmaceuticals (Eylea) Key News
7.2 Allergan
7.2.1 Allergan Corporate Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Intravitreal Injectable Major Product Offerings
7.2.4 Allergan Intravitreal Injectable Sales and Revenue in Global (2017-2022)
7.2.5 Allergan Key News
7.3 EyePoint Pharmaceuticals
7.3.1 EyePoint Pharmaceuticals Corporate Summary
7.3.2 EyePoint Pharmaceuticals Business Overview
7.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Major Product Offerings
7.3.4 EyePoint Pharmaceuticals Intravitreal Injectable Sales and Revenue in Global (2017-2022)
7.3.5 EyePoint Pharmaceuticals Key News
7.4 Genentech
7.4.1 Genentech Corporate Summary
7.4.2 Genentech Business Overview
7.4.3 Genentech Intravitreal Injectable Major Product Offerings
7.4.4 Genentech Intravitreal Injectable Sales and Revenue in Global (2017-2022)
7.4.5 Genentech Key News
7.5 Kanghong Pharmaceutical
7.5.1 Kanghong Pharmaceutical Corporate Summary
7.5.2 Kanghong Pharmaceutical Business Overview
7.5.3 Kanghong Pharmaceutical Intravitreal Injectable Major Product Offerings
7.5.4 Kanghong Pharmaceutical Intravitreal Injectable Sales and Revenue in Global (2017-2022)
7.5.5 Kanghong Pharmaceutical Key News
8 Global Intravitreal Injectable Production Capacity, Analysis
8.1 Global Intravitreal Injectable Production Capacity, 2017-2028
8.2 Intravitreal Injectable Production Capacity of Key Manufacturers in Global Market
8.3 Global Intravitreal Injectable Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Intravitreal Injectable Supply Chain Analysis
10.1 Intravitreal Injectable Industry Value Chain
10.2 Intravitreal Injectable Upstream Market
10.3 Intravitreal Injectable Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Intravitreal Injectable Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer